MORE►
Ben Lamm
Kristyn Jones, right, then an assistant secretary of the Air Force, pets a Belgian Malinois puppy at Joint Base San Antonio-Lackland in 2023. A program at the base breeds an estimated 10% to 15% of U.S. military dogs. [Photo: Air Force Airman 1st Class Gabriel Jones]
Dallas Startup Warhound Raises $200M to Genetically Engineer and Clone Elite Military Dogs
by John Egan | Oct 27, 2026
Warhound, co-founded by Ben Lamm of Dallas-based Colossal Biosciences, seeks to decrease reliance on working dogs from European breeders.
by Sandra Engelland |
Oct 14, 2026
The Dallas-based de-extinction company said its GenoMorph platform continues a series of breakthroughs aimed at reviving extinct and endangered species.
MORE►
by Sandra Engelland |
Sep 17, 2026
The foundation and IUCN Species Survival Commission have launched a four-year partnership that will use Colossal Biosciences’ technology to improve tracking of endangered species, including overlooked fungi, plants, invertebrates, fishes and reptiles.
MORE►
by Lauren Lawley Head |
Aug 20, 2026
The Dallas-based Colossal Biosciences spinout, now valued at $3.8 billion, is preparing forecasting pilots in health and biosecurity as it scales the model behind its predictions.
MORE►
Colossal BioVault, located at Colossal Biosciences' headquarters in Dallas. [Photo: Colossal]
Dallas-Based Colossal and U.S. Fish and Wildlife Service Launch BioVault Initiative for Endangered Species
by Sandra Engelland | Jun 25, 2026
"By preserving the genetic blueprint of every endangered species in America, we're creating a living archive of Earth's biodiversity—a modern-day Noah's Ark built from DNA and a permanent genetic backup of our nation's most imperiled species," said Colossal Biosciences Co-Founder and CEO Ben Lamm.
MORE►
by Quincy Preston and Sandra Engelland |
May 19, 2026
The Dallas biotech says the shell-less incubation platform could help revive species such as the South Island Giant Moa, whose massive eggs exceed the capacity of any living bird surrogate.
MORE►
by Quincy Preston |
Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
MORE►
by David Seeley |
Feb 3, 2026
"We're losing species at an alarming rate, and the world urgently needs a distributed network of global BioVaults—a true backup plan for life on Earth," said Ben Lamm, Colossal BioSciences' co-founder and CEO.
MORE►
Bolson tortoise (Gopherus flavomarginatus) [Photo: Colossal Foundation]
Colossal Foundation Invests $500K to Restore America’s Largest Tortoise to the Southwest
by Lance Murray | Nov 13, 2025
The Bolson tortoise is North America's largest and rarest tortoise species. Its population has grown from 23 adults to over 800 individuals through captive breeding, with over 150 juveniles released since 2021 showing 80%+ survival rates.
MORE►
by Glenn Hunter |
Nov 5, 2025
From North Texas founders including John Carmack and Ben Lamm to investors like John Redgrave of DTX Ventures and Draper’s Andy Tang, the summit's speakers tackled hot topics from humanoid robots and tech transfer to AI, VC trends and Y’all Street. A call was also heard for more risk-taking by DFW’s innovation ecosystem: ‘We’ve got to be bravery hunters.’
MORE►
by Quincy Preston |
Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by David Seeley |
Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE►
Colossal Co-Founder and CEO Ben Lamm (left) with Colossal Chief Biology Officer, Andrew Pask Ph.D. [Photo: Colossal]
Colossal Biosciences Names Australian De‑Extinction Scientist as Its Chief Biology Officer
by Lance Murray | Aug 20, 2025
Andrew Pask is known for his expertise in de-extinction science, developmental genetics, and conservation technologies. He leads the Thylacine Integrated Genomic Restoration Research Lab (TIGGR) at the University of Melbourne in Australia.
MORE►
![The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]](https://s24806.pcdn.co/wp-content/uploads/2025/07/Colossal-Moa-360x203.jpg)
by Quincy Preston |
Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE►
by Quincy Preston |
Jun 26, 2025
While TIME put Maximum Effort and Waymo on its 2025 worldwide covers, Dallas future-shaping companies are in the mix. Two are Dallas-based. Another Texas company—now a $2B brand—got its start here, too.
MORE►
by Quincy Preston |
Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE►
